These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 25983164)
1. The future of BRS in bifurcations. Kraak RP; Grundeken MJ; Onuma Y; Tu S; Wykrzykowska JJ; Chevalier B; Ormiston J; Serruys PW EuroIntervention; 2015; 11 Suppl V():V188-92. PubMed ID: 25983164 [TBL] [Abstract][Full Text] [Related]
2. Bioresorbable vascular scaffolds: the shape of things to come? Safian RD Catheter Cardiovasc Interv; 2012 Sep; 80(3):472-3. PubMed ID: 22431381 [No Abstract] [Full Text] [Related]
3. Technology limitations of BRS in bifurcations. Fox J; Hossainy S; Rapoza R; Serruys PW EuroIntervention; 2015; 11 Suppl V():V155-8. PubMed ID: 25983156 [TBL] [Abstract][Full Text] [Related]
4. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions. Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860 [No Abstract] [Full Text] [Related]
5. Local Flow Patterns After Implantation of Bioresorbable Vascular Scaffold in Coronary Bifurcations - Novel Findings by Computational Fluid Dynamics. Li Y; Li Z; Holck EN; Xu B; Karanasos A; Fei Z; Chang Y; Chu M; Dijkstra J; Christiansen EH; Reiber JHC; Holm NR; Tu S Circ J; 2018 May; 82(6):1575-1583. PubMed ID: 29576586 [TBL] [Abstract][Full Text] [Related]
6. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions. Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679 [TBL] [Abstract][Full Text] [Related]
7. Bioresorbable vascular scaffolds in left main coronary artery disease. Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148 [TBL] [Abstract][Full Text] [Related]
8. When and how to use BRS in bifurcations? Stankovic G; Lassen JF EuroIntervention; 2015; 11 Suppl V():V185-7. PubMed ID: 25983163 [TBL] [Abstract][Full Text] [Related]
10. Is it safe to implant bioresorbable scaffolds in ostial side-branch lesions? Impact of 'neo-carina' formation on main-branch flow pattern. Longitudinal clinical observations. Karanasos A; Li Y; Tu S; Wentzel JJ; Reiber JH; van Geuns RJ; Regar E Atherosclerosis; 2015 Jan; 238(1):22-5. PubMed ID: 25437885 [TBL] [Abstract][Full Text] [Related]
11. Lessons from the GHOST-EU registry. Latib A; Capodanno D; Lesiak M; Tamburino C; Colombo A EuroIntervention; 2015; 11 Suppl V():V170-4. PubMed ID: 25983159 [TBL] [Abstract][Full Text] [Related]
12. Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology. Costa JR; Abizaid A Methodist Debakey Cardiovasc J; 2018; 14(1):42-49. PubMed ID: 29623171 [TBL] [Abstract][Full Text] [Related]
13. Paving the way to a bioresorbable technology: Development of the absorb BRS program. Perkins LE; Kossuth MB; Fox JC; Rapoza RJ Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462 [TBL] [Abstract][Full Text] [Related]
14. Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation. Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Latib A; Colombo A Int J Cardiol; 2014 Dec; 177(2):607-9. PubMed ID: 25443250 [No Abstract] [Full Text] [Related]
16. Is there a need for dedicated devices? Wykrzykowska JJ; Grundeken MJ; Stankovic G; Di Mario C EuroIntervention; 2015; 11 Suppl V():V139-42. PubMed ID: 25983149 [TBL] [Abstract][Full Text] [Related]